33.47
                                            Ultragenyx Pharmaceutical Inc (RARE) 最新ニュース
Dosing begins in broader trial of experimental Angelman therapy - Angelman Syndrome News
Is Ultragenyx Pharmaceutical Inc. stock attractive for long term wealth buildingOil Prices & Free Technical Pattern Based Buy Signals - newser.com
Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly data2025 Market Overview & Technical Pattern Based Signals - newser.com
Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Will Ultragenyx Pharmaceutical Inc. stock remain a Wall Street favorite2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Earnings visualization tools for Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Weekly Momentum Picks - newser.com
Can Ultragenyx Pharmaceutical Inc. (UP0) stock surprise with quarterly results2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com
Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownQuarterly Performance Summary & Daily Volume Surge Signals - newser.com
Is this a good reentry point in Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com
Is Ultragenyx Pharmaceutical Inc. stock a buy in volatile marketsAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
Pinnacle Associates Ltd. Sells 29,107 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Chart based analysis of Ultragenyx Pharmaceutical Inc. trends - newser.com
Is Ultragenyx Pharmaceutical Inc. still worth holding after the dipTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTrade Entry Summary & High Yield Equity Trading Tips - newser.com
Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growthJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
How risky is Ultragenyx Pharmaceutical Inc. stock nowJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Can Ultragenyx Pharmaceutical Inc. stock deliver sustainable ROEJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Is Ultragenyx Pharmaceutical Inc. stock attractive after correctionWatch List & Long Hold Capital Preservation Plans - newser.com
Y Intercept Hong Kong Ltd Grows Stake in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Is Ultragenyx Pharmaceutical Inc. stock dividend yield sustainablePortfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Will Ultragenyx Pharmaceutical Inc. see short term momentum2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com
Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Ultragenyx Pharmaceutical Inc expected to post a loss of $1.23 a shareEarnings Preview - TradingView
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL) - The Globe and Mail
Ultragenyx doses first subject in study of GTX-102 for angelman syndrome - Clinical Trials Arena
What hedge fund moves indicate for Ultragenyx Pharmaceutical Inc. (UP0) stockTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Emerald Mutual Fund Advisers Trust Trims Stock Holdings in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Can Ultragenyx Pharmaceutical Inc. stock weather global recessionJuly 2025 Market Mood & Verified Technical Trade Signals - newser.com
Ultragenyx Pharmaceutical Inc. (RARE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Ultragenyx Begins Dosing in Aurora Study for Angelman Syndrome - TipRanks
                大文字化:
                 
                  | 
                ボリューム (24 時間):